-
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: a systematic review
Oosthoek, M., Vermunt, L., de Wilde, A., Bongers, B., Antwi-Berko, D., Scheltens, P., van Bokhoven, P., Vijverberg, E. G. B. & Teunissen, C. E., 1 Dec 2024, In: Alzheimer's Research and Therapy. 16, 1, 93.Research output: Contribution to journal › Article › Academic › peer-review
-
ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer’s Disease Patients
Oosthoek, M., Lili, A., Almeida, A., van Loosbroek, O., van der Geest, R., de Greef-van der Sandt, I., van Bokhoven, P., Sikkes, S. A. M., Teunissen, C. E. & Vijverberg, E. G. B., 1 Nov 2023, In: Journal of Prevention of Alzheimer's Disease. 10, 4, p. 669-674 6 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
